deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT01754519

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Phase II Trial of Single Fraction Radiation Therapy (SFRT) at Roswell Park Cancer Institute for Select Patients With Early Stage Breast Cancer

Sponsor: Cianna Medical, Inc.

Conditions Ductal Breast Carcinoma In Situ Estrogen Receptor Negative Estrogen Receptor Positive HER2/Neu Negative Invasive Cribriform Breast Carcinoma Invasive Ductal Carcinoma, Not Otherwise Specified Lobular Breast Carcinoma In Situ Mucinous Breast Carcinoma Papillary Breast Carcinoma Progesterone Receptor Positive Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIC Breast Cancer Tubular Breast Carcinoma
Interventions Laboratory Biomarker Analysis Quality-of-Life Assessment Radiation Therapy Therapeutic Conventional Surgery
Updated 11 times since 2017 Last updated: Jun 7, 2017 Started: May 31, 2013 Primary completion: Aug 31, 2015 Completion: Aug 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

IDE not submitted

Listed as NCT01754519, this PHASE2 trial focuses on Ductal Breast Carcinoma In Situ and Estrogen Receptor Negative and remains terminated or withdrawn. Sponsored by Cianna Medical, Inc., it has been updated 11 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jul 2017 · 5 months · monthly snapshotTerminated~Jul 2017 – ~Aug 2017 · 31 days · monthly snapshotTerminated~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE2

▶ Show 6 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE2

  2. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  3. Aug 2017 — Jun 2018 [monthly]

    Terminated PHASE2

  4. Jul 2017 — Aug 2017 [monthly]

    Terminated PHASE2

  5. Feb 2017 — Jul 2017 [monthly]

    Terminated PHASE2

  6. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cianna Medical, Inc.
  • National Cancer Institute (NCI)
  • Roswell Park Cancer Institute
Data source: Roswell Park Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations